Cytek BioSciences Inc
CTKB
Market Cap$665.42M
Close$
$1.53
46.2% downside
Current Fair Value
46.2% downsideOvervalued by 46.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $665.42 Million |
|---|---|
| Enterprise Value | $611.52 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.09 |
| Beta | 1.31 |
| Outstanding Shares | 131,440,486 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -37.88 |
|---|---|
| PEG | -44.66 |
| Price to Sales | 2.85 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 3.1 |
| Enterprise Value to EBIT | -23.36 |
| Enterprise Value to Net Income | -55 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cytek BioSciences Inc
2,021 employees